Does Megace (megestrol acetate) exacerbate heart failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Megace (megestrol acetate) can potentially worsen heart failure in some patients due to its fluid retention effects, which can exacerbate heart failure symptoms. This medication, commonly used to stimulate appetite in patients with cancer or HIV-related weight loss, has been associated with fluid retention which can worsen heart failure symptoms. The fluid retention effect is due to its progesterone-like properties, which can cause sodium and water retention in the body. Patients with pre-existing heart failure or those at risk for cardiovascular disease should be monitored closely if prescribed Megace, as stated in various guidelines, including those from the American College of Cardiology Foundation and American Heart Association 1.

Key Considerations

  • Patients with heart failure should be monitored for signs of worsening heart failure, including increased shortness of breath, swelling in the legs or ankles, sudden weight gain, and increased fatigue.
  • The management of heart failure involves a multifaceted approach, including the use of ACE inhibitors, beta blockers, and diuretics, as recommended by guidelines such as those from the National Institute for Health and Clinical Excellence 1.
  • Alternative appetite stimulants might be considered if the risks of Megace outweigh its benefits in a specific situation, taking into account the individual patient's risk-benefit profile and the potential for fluid retention and worsening heart failure symptoms.

Monitoring and Management

  • Regular monitoring of weight, blood pressure, and signs of fluid retention is crucial for patients with heart failure who are taking Megace.
  • Healthcare providers should be vigilant for signs of worsening heart failure and adjust treatment accordingly, which may include adjusting heart failure medications or reconsidering the use of Megace, as supported by evidence from studies on heart failure management 1.

From the Research

Megace and Heart Failure

  • There is no direct evidence in the provided studies that discusses the effect of Megace on heart failure.
  • The studies focus on various aspects of heart failure, including fluid balance 2, 3, 4, beta-blocker therapy 5, and medical treatment of chronic heart failure 6.
  • None of the studies mention Megace, which suggests that there may not be sufficient research on the topic to provide a conclusive answer.
  • However, it is known that certain medications can exacerbate heart failure, and it is essential to carefully evaluate the potential effects of any medication on heart failure patients 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Fluid balance in heart failure.

European journal of preventive cardiology, 2023

Research

Pathophysiology of fluid retention in heart failure.

Contributions to nephrology, 2010

Research

Fluid management strategies in heart failure.

Critical care nurse, 2012

Research

beta-Blocker therapy in heart failure.

Heart failure monitor, 2000

Related Questions

What is the next step for a 45-year-old female presenting with left chest and neck pain, with a background of severe Tricuspid (tricuspid valve) regurgitation and a dilated right ventricle?
What is the next step for a patient with severe aortic stenosis (Aortic Valve Stenosis) and a gradient greater than 40mmHg, presenting with fluid overload and pulmonary edema (crackle), and an ejection fraction (EF) of 50%?
Are isotonic fluids contraindicated in Congestive Heart Failure (CHF)?
What is the relationship between Bosentan (Tracleer) and fluid retention?
What treatment adjustments are needed for a 44-year-old female patient with diastolic heart failure, recent exacerbation, and difficulty managing fluid overload with current Lasix (furosemide) 60mg regimen, presenting with bilateral lower extremity edema (BLE), mild ascites, orthopnea, and impaired renal function?
What are the key observations post-total thyroidectomy?
What is the significance of a 10 millimeter soft tissue, non-vascular splenic nodule in a 26-year-old female patient?
What is the difference between Peripheral T-cell Lymphoma (PTCL) and Angioimmunoblastic T-cell Lymphoma (AITL)?
What is the purpose of a haptoglobin (Hp) test?
What are the guidelines for Intravenous Immunoglobulin (IVIG) administration in newborns (neonates)?
What is the incidence of new-onset atrial fibrillation (a fib) after minimally invasive mitral valve repair in patients with severely dilated left atrium and preserved left ventricular ejection fraction, and what treatment options are available, including intravenous Amiodarone (amiodarone)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.